Our multivariate competing risk analysis (adjusted for age, sex, race/ethnicity, blood type, diabetes, obesity, MELD score, tumor size in cm, AFP, UNOS region, locoregional therapies, and college education) included 2311 complete cases (Figure 1). This evidence concerns the gene AFP and obesity disorder.